Ginkgo Bioworks Holdings (DNA) Stock Analysis

Ginkgo Bioworks Holdings (DNA) is a publicly traded company in the HEALTHCARE sector. It trades at $9.34, carries a market capitalization of $593.15M. This page summarizes the public market data, fundamentals, and frequently asked questions for DNA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE

Key Metrics

• Price: $9.34
• Market Cap: $593.15M
• EPS: $-5.38
• 52-Week High: $17.58
• 52-Week Low: $5.37

Market Sentiment

Ginkgo Bioworks Holdings currently has a Bearish sentiment score of -0.45.

About Ginkgo Bioworks Holdings

None

GNG Research Analysis

GNG Research scores Ginkgo Bioworks Holdings (DNA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DNA.

Frequently Asked Questions

Does DNA pay dividends?

Ginkgo Bioworks Holdings (DNA) does not currently pay a regular dividend.

What is DNA's market cap?

Ginkgo Bioworks Holdings (DNA) has a market capitalization of $593.15M with a current stock price of $9.34.